Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization
- PMID: 11723030
- DOI: 10.1161/hc4601.099487
Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization
Abstract
This two-part article provides an overview of the global burden of atherothrombotic cardiovascular disease. Part I initially discusses the epidemiologic transition which has resulted in a decrease in deaths in childhood due to infections, with a concomitant increase in cardiovascular and other chronic diseases; and then provides estimates of the burden of cardiovascular (CV) diseases with specific focus on the developing countries. Next, we summarize key information on risk factors for cardiovascular disease (CVD) and indicate that their importance may have been underestimated. Then, we describe overarching factors influencing variations in CVD by ethnicity and region and the influence of urbanization. Part II of this article describes the burden of CV disease by specific region or ethnic group, the risk factors of importance, and possible strategies for prevention.
Similar articles
-
Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies.Circulation. 2001 Dec 4;104(23):2855-64. doi: 10.1161/hc4701.099488. Circulation. 2001. PMID: 11733407
-
Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.Eur Heart J. 2010 Mar;31(6):642-8. doi: 10.1093/eurheartj/ehq030. Epub 2010 Feb 22. Eur Heart J. 2010. PMID: 20176800 Review.
-
Urbanization is Associated with Increased Trends in Cardiovascular Mortality Among Indigenous Populations: the PAI Study.Arq Bras Cardiol. 2018 Mar;110(3):240-245. doi: 10.5935/abc.20180026. Epub 2018 Feb 19. Arq Bras Cardiol. 2018. PMID: 29466492 Free PMC article.
-
Cardiovascular disease in developing countries: myths, realities, and opportunities.Cardiovasc Drugs Ther. 1999 Apr;13(2):95-104. doi: 10.1023/a:1007727924276. Cardiovasc Drugs Ther. 1999. PMID: 10372224 Review.
-
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.Lancet. 1997 May 17;349(9063):1436-42. doi: 10.1016/S0140-6736(96)07495-8. Lancet. 1997. PMID: 9164317
Cited by
-
Unwillingness to participate in health checks for cardiometabolic diseases: A survey among primary health care patients in five European countries.Health Sci Rep. 2021 Mar 24;4(2):e256. doi: 10.1002/hsr2.256. eCollection 2021 Jun. Health Sci Rep. 2021. PMID: 33778166 Free PMC article.
-
Hypertension in a Brazilian urban slum population.J Urban Health. 2015 Jun;92(3):446-59. doi: 10.1007/s11524-015-9956-1. J Urban Health. 2015. PMID: 25920334 Free PMC article.
-
Efficacy and tolerability of a β-1 selective β blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study.BMJ Open. 2012 May 14;2(3):e000683. doi: 10.1136/bmjopen-2011-000683. Print 2012. BMJ Open. 2012. PMID: 22586283 Free PMC article.
-
Survival rate and predictors of 36-month mortality in patients with heart failure in Sub Saharan Africa: insights from the Douala Heart Failure Registry (Do-HF).Cardiovasc Diagn Ther. 2022 Oct;12(5):577-588. doi: 10.21037/cdt-22-166. Cardiovasc Diagn Ther. 2022. PMID: 36329966 Free PMC article.
-
Prevalence and risk factors of atrioventricular block among 15 million Chinese health examination participants in 2018: a nation-wide cross-sectional study.BMC Cardiovasc Disord. 2021 Jun 11;21(1):289. doi: 10.1186/s12872-021-02105-3. BMC Cardiovasc Disord. 2021. PMID: 34116630 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
